Skip to main content
Clinical Trials/NCT01081002
NCT01081002
Completed
Phase 4

Study of Propofol Sedation During Upper Endoscopy With and Without Topical Pharyngeal Anesthesia

University Hospital, Basel, Switzerland2 sites in 1 country294 target enrollmentAugust 2009

Overview

Phase
Phase 4
Intervention
Lidocaine 10%
Conditions
Conscious Sedation
Sponsor
University Hospital, Basel, Switzerland
Enrollment
294
Locations
2
Primary Endpoint
Number triggered gag reflex during the intubation of the endoscope
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

It is unclear whether a topical pharyngeal anesthesia adds any benefit to the upper gastrointestinal endoscopy under a propofol sedation. We hypothesize that a topical pharyngeal anesthesia does not ease the upper gastrointestinal endoscopy under propofol sedation. The aim of this study is therefore to quantify the impact of a topical pharyngeal anesthesia to the upper gastrointestinal endoscopy in patients sedated with propofol.

Patients will be randomized to receive a topical pharyngeal spray containing either an anesthetic drug (lidocaine 10%) or a placebo. Thereafter the upper endoscopy will be conducted in its standard manner.

Registry
clinicaltrials.gov
Start Date
August 2009
End Date
May 2010
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Principal Investigator
Principal Investigator

Lukas Degen

Prof.

University Hospital, Basel, Switzerland

Eligibility Criteria

Inclusion Criteria

  • Scheduled diagnostic upper endoscopy
  • Wish to be sedated
  • ASA class I - III
  • Signed informed consent

Exclusion Criteria

  • Emergency medical examinations
  • Therapeutic Endoscopy
  • ASA class IV
  • Pregnancy
  • Known allergy to propofol or lidocaine

Arms & Interventions

Anesthesia (=A) with lidocaine 10%

3 min before sedation 4 puffs of terbutaline diluted lidocaine solution (Xylocaine ® 10% spray, Astra Zeneca, London, UK) will be sprayed on the pharynx

Intervention: Lidocaine 10%

A with diluted gentian root solution

3 min before sedation 4 puffs of highly diluted gentian solution will be sprayed on the pharynx

Intervention: Diluted gentian root solution

Outcomes

Primary Outcomes

Number triggered gag reflex during the intubation of the endoscope

Time Frame: Start of the exam until the successful intubation of the esophagus with the endoscope

Number of attempts of intubation with the endoscope through the upper esophageal sphincter

Time Frame: Start of the exam until the successful intubation of the esophagus with the endoscope

Extent of salivation during intubation

Time Frame: Start of the exam until the successful intubation of the esophagus with the endoscope

Secondary Outcomes

  • The impact of the individual endoscopists or registered nurses involved in the endoscopy(After finishing the entire study)
  • Overall assessment of the investigation by the patient(Immediately after recovery of consciousness of the patient)
  • Amount of propofol used to successfully intubate the esophagus(Start of the exam until the successful intubation of the esophagus with the endoscope)
  • Total amount of propofol used during the investigation(From the start until the end of the exam)
  • Extent of amnesia in the patient(Immediately after recovery of consciousness of the patient)
  • Experienced problems (aspiration, bronchospasm, desaturation)(From the start until the end of the exam)
  • Assumption of the endoscopist if lidocaine or placebo has been used(Immediately after finishing the endoscopy)
  • Overall assessment of the procedure by the endoscopist(Immediately after finishing the endoscopy)

Study Sites (2)

Loading locations...

Similar Trials